Exelixis
EXEL
#1684
Rank
HK$78.70 B
Marketcap
HK$275.59
Share price
1.65%
Change (1 day)
66.60%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company